Contribute Try STAT+ Today

The latest high-profile incident of a ransomware attack caused one of the biggest gas and fuel suppliers in the U.S. to close its East Coast pipeline for several days, a worrisome reminder that each industry remains vulnerable to cyberattacks. And not surprisingly, pharmaceutical companies also are easy targets, according to a new analysis.

To wit, nearly 10% of drug makers are “highly” susceptible to a ransomware attack and 43% of the industry’s data management vendors are likely to incur such an attack. And almost half of 200 drug companies have more than 1,000 employees whose user names and passwords were exposed on the deep web in the last 90 days, according to Black Kite, a cybersecurity consulting firm.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • To quote the not-so-old saw – “It’s not a question of IF, but WHEN.”

Comments are closed.